Alembic Pharmaceuticals informs about press release

08 Mar 2023 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Prazosin Hydrochloride Capsules USP, 1 mg, 2 mg, and 5 mg. In this regard, the company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1045.95 -9.05 (-0.86%)
23-Dec-2024 14:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.20
Dr. Reddys Lab 1345.15
Cipla 1477.15
Lupin 2166.25
Zydus Lifesciences 974.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.